RJFSA
IMMU

Raymond James Financial Services Advisors’s Immunomedics Inc IMMU Stock Holding History

Raymond James Financial Services Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,744
Closed -$239K – 3034
2020
Q2 		$239K Buy
+6,744
New +$197K ﹤0.01% 2379
2020
Q1 		– Sell
-16,274
Closed -$344K – 2943
2019
Q4 		$344K Sell
16,274
-306
-2% -$5.4K ﹤0.01% 2238
2019
Q3 		$220K Buy
+16,580
New +$244K ﹤0.01% 2430
2017
Q4 		– Sell
-12,400
Closed -$173K – 2749
2017
Q3 		$173K Sell
12,400
-2,000
-14% -$19.9K ﹤0.01% 2318
2017
Q2 		$127K Buy
14,400
+1,473
+11% +$10.3K ﹤0.01% 2316
2017
Q1 		$84K Sell
12,927
-3,849
-23% -$19.5K ﹤0.01% 2281
2016
Q4 		$62K Hold
16,776
– – ﹤0.01% 2223
2016
Q3 		$55K Sell
16,776
-7,000
-29% -$19.6K ﹤0.01% 2202
2016
Q2 		$55K Sell
23,776
-176
-0.7% -$588 ﹤0.01% 2170
2016
Q1 		$60K Buy
+23,952
New +$53.9K ﹤0.01% 1950

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Raymond James Financial Services Advisors's IMMU Position: Q3 2020 in Review

Raymond James Financial Services Advisors sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 6,744 shares — an estimated $239K sold.

Raymond James Financial Services Advisors first reported a position in IMMU in Q1 2016 and held it in 10 quarters. The position peaked at $344K in Q4 2019. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Raymond James Financial Services Advisors reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 6,744 Immunomedics Inc shares in Q3 2020, an estimated $239K.
  • Raymond James Financial Services Advisors first reported a position in Immunomedics Inc in Q1 2016 and held it in 10 quarters.
  • Raymond James Financial Services Advisors's Immunomedics Inc position peaked at $344K in Q4 2019.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2020, filed 4 Nov 2020.